[Long-term treatment of advanced lymphogranulomatosis using cytotoxic agents (Velbe, Natulan, Endoxan and Vincristine)].
D000970:Antineoplastic Agents / Q000009:adverse effects*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D006834:Hydrazines / Q000009:adverse effects*; D013997:Time Factors; D014747:Vinblastine / Q000009:adverse effects*; D014750:Vincristine / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D006834:Hydrazines; D014750:Vincristine; D014747:Vinblastine; D003520:Cyclophosphamide
Langzeitbehandlung der fortgeschrittenen Lymphogranulomatose mit Cytostatika (Velbe, Natulan, Endoxan und Vincristin)